UC San Francisco Cell Therapy Raises Hope for Severe Human Forms
Epilepsy that does not respond to drugs can be halted in adult mice by transplanting a specific type of cell into the brain, UC San Francisco researchers have discovered, raising hope that a similar treatment might work in severe forms of human epilepsy.
UCSF scientists controlled seizures in epileptic mice with a one-time transplantation of medial ganglionic eminence (MGE) cells, which inhibit signaling in overactive nerve circuits, into the hippocampus, a brain region associated with seizures, as well as with learning and memory. Other researchers had previously used different cell types in rodent cell transplantation experiments and failed to stop seizures.
Cell therapy has become an active focus of epilepsy research, in part because current medications, even when effective, only control symptoms and not underlying causes of the disease, according to Scott C. Baraban, PhD, who holds the William K. Bowes Jr. Endowed Chair in Neuroscience Research at UCSF and led the new study. In many types of epilepsy, he said, current drugs have no therapeutic value at all.
“Our results are an encouraging step toward using inhibitory neurons for cell transplantation in adults with severe forms of epilepsy,” Baraban said. “This procedure offers the possibility of controlling seizures and rescuing cognitive deficits in these patients.”
The findings, which are the first ever to report stopping seizures in mouse models of adult human epilepsy, will be published online May 5 in the journal Nature Neuroscience.
During epileptic seizures, extreme muscle contractions and, often, a loss of consciousness can cause seizure sufferers to lose control, fall and sometimes be seriously injured. The unseen malfunction behind these effects is the abnormal firing of many excitatory nerve cells in the brain at the same time.
In the UCSF study, the transplanted inhibitory cells quenched this synchronous, nerve-signaling firestorm, eliminating seizures in half of the treated mice and dramatically reducing the number of spontaneous seizures in the rest. Robert Hunt, PhD, a postdoctoral fellow in the Baraban lab, guided many of the key experiments.
In another encouraging step, UCSF researchers reported May 2 that they found a way to reliably generate human MGE-like cells in the laboratory, and that, when transplanted into healthy mice,the cells similarly spun off functional inhibitory nerve cells. That research can be found online in the journal Cell Stem Cell.
In many forms of epilepsy, loss or malfunction of inhibitory nerve cells within the hippocampus plays a critical role. MGE cells are progenitor cells that form early within the embryo and are capable of generating mature inhibitory nerve cells called interneurons. In the Baraban-led UCSF study, the transplanted MGE cells from mouse embryos migrated and generated interneurons, in effect replacing the cells that fail in epilepsy. The new cells integrated into existing neural circuits in the mice, the researchers found.
“These cells migrate widely and integrate into the adult brain as new inhibitory neurons,” Baraban said. “This is the first report in a mouse model of adult epilepsy in which mice that already were having seizures stopped having seizures after treatment.”
The mouse model of disease that Baraban’s lab team worked with is meant to resemble a severe and typically drug-resistant form of human epilepsy called mesial temporal lobe epilepsy, in which seizures are thought to arise in the hippocampus. In contrast to transplants into the hippocampus, transplants into the amygdala, a brain region involved in memory and emotion, failed to halt seizure activity in this same mouse model, the researcher found.
The Latest Bing News on:
Epilepsy
- Nicklaus Children’s Hospital and Patients Celebrate 40 Years of Epilepsy Surgery Innovationon May 2, 2024 at 3:51 pm
Nicklaus Children’s Hospital’s Brain Institute celebrated the 40th anniversary of its Epilepsy Surgery Program in March with a patient reunion at Zoo Miami. The fun-filled event was attended by nearly ...
- Sleep Apnea Linked With Late-Life Epilepsyon May 2, 2024 at 2:46 am
The link between epilepsy and the breathing disorders of sleep apnea was strong: "People whose oxygen saturation fell below 80% during sleep, a condition known as nocturnal hypoxia, were three times ...
- Atlanta EEG Testing & Neurodiagnostic Care For Epilepsy Patients Service Expandson May 2, 2024 at 12:58 am
McKinney, United States - May 1, 2024 — The healthcare practice is now providing more accessible neurodiagnostic care solutions for individuals suffering from epilepsy and other serious neurological ...
- Emergency departments may frequently miss signs of epilepsy in childrenon May 1, 2024 at 1:00 pm
A subtle type of seizure goes undetected two thirds of the time in pediatric emergency departments, a new study shows.
- National Institutes of Health (NIH) Study Finds Low Oxygen During Sleep and Sleep Apnea Linked to Epilepsy in Older Adultson May 1, 2024 at 6:49 am
Findings provide further insight into the complex relationship between sleep disorders and epilepsy ...
- Epilepsy patients concerned about out-of-pocket costs of medicationson April 30, 2024 at 4:38 pm
GREENWOOD, Ind. — Of the roughly 70,000 Hoosiers who suffer from epilepsy, several have started to express concerns that the out-of-pocket costs for their medications have gotten out of hand. One ...
- Hoosiers express epilepsy medicine cost concernson April 30, 2024 at 2:57 pm
Special Weather Statement: Boone County, Carroll County, Clay County, Clinton County, Fountain County, Greene County, Hendricks County, Owen County, Parke County, Putnam County, Tippecanoe County, ...
- Harmony Biosciences shares soar on acquisition of New Jersey epilepsy drug developeron April 30, 2024 at 8:31 am
The deal consists of an upfront payment of $35 million and potential milestone payments of up to $645 million.
- Sweet Harmony: Neuro biotech buys Epygenix and its epilepsy meds for $35M upfronton April 30, 2024 at 7:04 am
Harmony Biosciences is adding a suite of epilepsy assets to its pipeline, buying Epygenix for $35 million upfront with more than $600 million in biobucks on the table. | Harmony Biosciences is ...
- People with epilepsy left ‘stranded and out of pocket’ due to rules around discounted travel passeson April 30, 2024 at 4:33 am
Northern Ireland has the highest epilepsy prevalence in the UK, with more than 23,000 people living with the condition ...
The Latest Google Headlines on:
Epilepsy
[google_news title=”” keyword=”Epilepsy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Cell therapy
- ClearPoint Neuro to Present Novel Research and Exhibit at the 27th American Society of Gene & Cell Therapy Annual Meeting in Baltimoreon May 2, 2024 at 9:05 am
SOLANA BEACH, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to ...
- Demand grows for outsourced cell therapy manufacturingon May 1, 2024 at 2:55 pm
In latest deal, Bristol Myers Squibb picks Cellares to manufacture its chimeric antigen receptor T-cell therapies for cancers ...
- Preclinical study finds novel stem cell therapy boosts neural repair after cardiac arreston May 1, 2024 at 10:13 am
Researchers at the University of Maryland School of Medicine (UMSOM) have identified an innovation in stem cell therapy to regenerate neural cells in the brain after cardiac arrest in an animal model.
- BioCardia’s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important Outcomeson May 1, 2024 at 6:01 am
SUNNYVALE, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NASDAQ: BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, ...
- Cell Therapy Manufacturing: Time to Move Faston April 30, 2024 at 9:54 am
The more quickly manufacturing and release obstructions can be cleared, the sooner lifesaving treatments can be administered.
- Can Brazil make cell and gene therapy costs affordable for all?on April 29, 2024 at 7:10 am
Found out how Brazil is attempting to make gene and cell therapy costs affordable for all with a new initiative.
- Cell and gene therapy companies trip at scalability hurdleon April 29, 2024 at 3:09 am
Experts hold scalability challenges and high costs accountable for market failures within the cell and gene therapy landscape.
- CD7 CAR T-Cell Therapy, Stem-Cell Transplant Beneficial for CD7-Positive Tumorson April 25, 2024 at 11:30 pm
For patients with relapsed or refractory CD7-positive leukemia or lymphoma, sequential CD7 chimeric antigen receptor (CAR) T-cell therapy followed by haploidentical hematopoietic stem-cell ...
- The murky, unregulated world of anti-ageing stem cell therapyon April 24, 2024 at 10:50 am
Stem cells are the new focal point of the rich and famous with Hollywood A-listers reportedly spending tens of thousands of pounds each year on expensive therapies offered by private longevity clinics ...
- CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in phase I trialon April 23, 2024 at 5:00 am
Researchers at Texas Children’s Cancer Center and the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children’s Hospital ...
The Latest Google Headlines on:
Cell therapy
[google_news title=”” keyword=”Cell therapy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]